Stroke in chronic kidney disease: prevention and management. - Wikidata - wikimedia - TriplyDB

Stroke in chronic kidney disease: prevention and management.

Stroke in chronic kidney disease: prevention and management.

http://www.wikidata.org/entity/Q35153302

about

Ischemic stroke among the patients with end-stage renal disease who were undergoing maintenance dialysis Estimated glomerular filtration rate decline in 567 patients with acute stroke.

P2860

Q36178116-1CAE6A2F-F3BE-4460-A0AF-F600093EAD82 Q45803591-226C6FDD-969E-47E4-8785-0ADD66BFBA7A

P2860

Stroke in chronic kidney disease: prevention and management.

http://www.wikidata.org/entity/Q35153302

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Stroke in chronic kidney disease: prevention and management.

@ast

Stroke in chronic kidney disease: prevention and management.

@en

type

label

Stroke in chronic kidney disease: prevention and management.

@ast

Stroke in chronic kidney disease: prevention and management.

@en

prefLabel

Stroke in chronic kidney disease: prevention and management.

@ast

Stroke in chronic kidney disease: prevention and management.

@en

P1433

Q35153302-53ED1177-C1EE-485C-93DA-C775ABEB61B4

P1476

Q35153302-E0CFE952-5F6B-4005-8FBE-A9ACCFAD7A3F

P2093

Q35153302-A6C17302-0B3B-4343-8A5E-86494EC40638

P2860

Q35153302-01388FE3-755D-4A08-BE16-942D891BE5AD

Q35153302-067EED50-A742-484C-A98D-463A79AAFC3E

Q35153302-083A311A-D6D2-4275-A638-77F80C8F0A82

Q35153302-10060104-F323-4060-A3F3-6D147B066AA5

Q35153302-21CCF255-5A58-4AE5-8678-04250E555C5F

Q35153302-2546311B-D7C0-44AE-A68B-8DACF65DE376

Q35153302-4484C4DE-19AE-4F0E-ACD3-F8178D3485C6

Q35153302-45B48841-699D-49F4-B85E-54E8079900C5

Q35153302-485F3B17-886D-4B68-8AEA-2BDD317200A2

Q35153302-4E3F61F3-C21B-4A7E-B527-B6315EDFBC15

P304

Q35153302-500956B8-91D0-4D62-B91C-FFFC47D4FCAD

P31

Q35153302-963D67AF-697A-400D-AA0A-3A7A06439CBF

P356

Q35153302-80CB5640-0A9B-49B4-984D-1A09E23A38E0

P478

Q35153302-2191677F-89F7-44B2-9809-6BA8384D9969

P577

Q35153302-78E8CED9-B1FD-453A-B354-1E7B18A967C3

P698

Q35153302-8E4EF4CD-DD44-42FB-A887-DA11D17F9C47

P932

Q35153302-9D39914B-DC45-4194-B396-5BE9B2CB5C22

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Stroke in chronic kidney disease: prevention and management.

@en

P2093

Raymond R Townsend

http://www.w3.org/2001/XMLSchema#string

P2860

Primary prevention of ischemic stroke

Expressing the magnitude of adverse effects in case-control studies: "the number of patients needed to be treated for one additional patient to be harmed"

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patient

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

P304

S11-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.03260807

http://www.w3.org/2001/XMLSchema#string

P478

3 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18178791

http://www.w3.org/2001/XMLSchema#string

P932

3152267

http://www.w3.org/2001/XMLSchema#string